These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 11407708
21. Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice. Sahebjam S, Khokha R, Mort JS. Arthritis Rheum; 2007 Mar; 56(3):905-9. PubMed ID: 17328064 [Abstract] [Full Text] [Related]
23. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR. Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762 [Abstract] [Full Text] [Related]
24. Neoepitope antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan. Fosang AJ, Last K, Stanton H, Golub SB, Little CB, Brown L, Jackson DC. Methods Mol Biol; 2010 Mar; 622():312-47. PubMed ID: 20135291 [Abstract] [Full Text] [Related]
27. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. Tchetina EV, Squires G, Poole AR. J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625 [Abstract] [Full Text] [Related]
29. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Cucchiarini M, Thurn T, Weimer A, Kohn D, Terwilliger EF, Madry H. Arthritis Rheum; 2007 Jan; 56(1):158-67. PubMed ID: 17195218 [Abstract] [Full Text] [Related]
34. Activation of cartilage matrix metalloproteinases by activated protein C. Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB. Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107 [Abstract] [Full Text] [Related]
36. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. Fosang AJ, Last K, Maciewicz RA. J Clin Invest; 1996 Nov 15; 98(10):2292-9. PubMed ID: 8941646 [Abstract] [Full Text] [Related]
37. Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants. Fosang AJ, Last K, Stanton H, Weeks DB, Campbell IK, Hardingham TE, Hembry RM. J Biol Chem; 2000 Oct 20; 275(42):33027-37. PubMed ID: 10882746 [Abstract] [Full Text] [Related]
39. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites. Tortorella MD, Pratta MA, Fox JW, Arner EC. J Biol Chem; 1998 Mar 06; 273(10):5846-50. PubMed ID: 9488721 [Abstract] [Full Text] [Related]